ROBIN SHERRINGTON 4
4 · Xenon Pharmaceuticals Inc. · Filed Mar 14, 2023
Insider Transaction Report
Form 4
ROBIN SHERRINGTON
See Remarks
Transactions
- Award
Stock Option (Right to Buy)
2023-03-10+75,000→ 75,000 totalExercise: $34.18Exp: 2033-03-09→ Common Shares (75,000 underlying)
Footnotes (1)
- [F1]Vesting 25% on January 1, 2024 and 75% vesting thereafter over the course of the next 3 years, in equal amounts, on the last day of each month.